Neovascular AMD necessitates repeated intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) drugs, whereas there are currently no clinical treatments available that can either slow progression or restore vision in cases of GA (2). This evidence concerns the gene VEGFA and age-related macular degeneration.